おすすめの製品
由来生物
goat
品質水準
結合体
biotin conjugate
抗体製品の状態
F(ab′)2 fragment of affinity isolated antibody
抗体製品タイプ
secondary antibodies
クローン
polyclonal
化学種の反応性
rabbit
メーカー／製品名
Chemicon®
濃度
1.1 mg/mL
テクニック
ELISA: suitable
western blot: suitable
輸送温度
wet ice
ターゲットの翻訳後修飾
unmodified
特異性
Rabbit IgG (H+L) (absorbed for minimal cross-reactivity to Human, Mouse and Rat Serum Proteins)
アプリケーション
Research Category
二次抗体及びコントロール抗体
二次抗体及びコントロール抗体
Research Sub Category
二重標識用 吸収処理済み二次抗体
二重標識用 吸収処理済み二次抗体
Suggested dilution for most applications:
1:50,000-1:1,000,000 for ELISA using enzyme-conjugated streptavidin
1:10,000-1:100,000 for western blotting with chemiluminescent substrates.
1:500-1:5,000 for enzyme immunoohistochemistry on tissue sections.
1:200-1:1,000 for flow cytometry and fluorescence immunohisto /cytochemistry
Optimal working dilutions must be determined by the end user.
1:50,000-1:1,000,000 for ELISA using enzyme-conjugated streptavidin
1:10,000-1:100,000 for western blotting with chemiluminescent substrates.
1:500-1:5,000 for enzyme immunoohistochemistry on tissue sections.
1:200-1:1,000 for flow cytometry and fluorescence immunohisto /cytochemistry
Optimal working dilutions must be determined by the end user.
This Goat anti-Rabbit IgG Antibody, biotin-SP conjugate, Species Adsorbed is validated for use in ELISA, WB for the detection of Rabbit IgG.
物理的形状
Lyophilized. Buffer = 0.01 M Sodium Phosphate, 0.25 M NaCl, pH 7.6 with 15 mg/mL BSA, 0.01% Thimerosal and 0.05% Sodium Azide
RECONSTITUTION:
Reconstitute with 1.5 mL sterile distilled water.
RECONSTITUTION:
Reconstitute with 1.5 mL sterile distilled water.
保管および安定性
Maintain lyophilized product at 2-8°C for up to 12 months. After reconstitution the product is stable for several weeks at 2-8°C as an undiluted liquid. For extended storage after reconstitution, add an equal volume of glycerol to make a final concentration of 50% glycerol followed by storage at -20°C with or without aliquotting for up to 12 months. Please note the concentration of protein (and buffer salts) will decrease to one-half of the original after the addition of glycerol.
法的情報
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
免責事項
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
適切な製品が見つかりませんか。
製品選択ツール.をお試しください
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
毒物及び劇物取締法
毒物
Jan Code
AP187B:
試験成績書（COA）
製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
The presence of B-type natriuretic peptide in burns and the responsiveness of fibroblasts to BNP: proof of principle.
Adam J Singer,Vladimir Jurukovski,Marcia Simon,Jing Ying Ma,Andrew Protter et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine null
p38 MAPK inhibition reduces diabetes-induced impairment of wound healing.
Medicherla, S; Wadsworth, S; Cullen, B; Silcock, D; Ma, JY; Mangadu, R; Kerr et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy null
Jing Ying Ma et al.
Journal of asthma and allergy, 1, 31-44 (2008-01-01)
p38 Mitogen-activated protein kinase (MAPK) plays a critical role in the activation of inflammatory cells. We investigated the anti-inflammatory effects of a p38α-selective MAPK inhibitor (SD-282) in a mouse transgenic (CC10:IL-13) asthma model. The CC-10-driven over-expression of IL-13 in the
Expression of hepatocyte epidermal growth factor receptor, FAS and glypican 3 in EpCAM-positive regenerative clusters of hepatocytes, cholangiocytes, and progenitor cells in human liver failure.
Hattoum, A; Rubin, E; Orr, A; Michalopoulos, GK
Human Pathology null
Mitchell J Bartlett et al.
Experimental neurology, 333, 113413-113413 (2020-07-28)
Parkinson's disease (PD) is the second most common neurodegenerative disease. Pharmacotherapy with L-DOPA remains the gold-standard therapy for PD, but is often limited by the development of the common side effect of L-DOPA-induced dyskinesia (LID), which can become debilitating. The
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）